FDA Approves Mysterious 'Field Generator Positioning Devices' for Brains
Published Date: 11/26/2025
Rule
Summary
The FDA has officially classified the field generator positioning device as a low-risk, Class I device, making it easier and faster for patients to get access to this helpful technology. This change reduces red tape for manufacturers without compromising safety or effectiveness. The new classification took effect on November 26, 2025, but has been in place since July 10, 2020, so no new costs or delays are expected.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Easier patient access to device
If you are a patient, the FDA has classified the field generator positioning device as Class I (general controls), and says this will enhance patients' access by reducing regulatory burdens. The final order is effective November 26, 2025, and the classification was applicable on July 10, 2020.
Manufacturers face lower premarket burden
If you manufacture or import this device, FDA placed the field generator positioning device in Class I (general controls) and states devices in this type are exempt from premarket notification (510(k)) under section 510(l)(1), except when the device is of substantial importance in preventing impairment of human health or presents a potentially unreasonable risk. FDA says this classification reduces regulatory burdens; the final order is effective November 26, 2025 and was applicable on July 10, 2020.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in